Literature DB >> 27337161

Predictors of seizures in patients with posterior reversible encephalopathy syndrome.

Archana Hinduja1, Kenneth Habetz2, Sunil Kumar Raina3, Ryan T Fitzgerald4, Kinshuk Sahaya5.   

Abstract

PURPOSE: Although seizures are common in patients with posterior reversible encephalopathy syndrome (PRES), epilepsy is rare. Our objective was to identify predictors and impact of seizures in patients with PRES.
METHODS: A retrospective review of the clinical and radiological parameters of all patients diagnosed with PRES from 2007 to 2014 was performed. Patients were divided into two groups based on the occurrence of PRES-related seizures at presentation or during their hospital course. Univariate and multivariate analyses were performed to determine factors associated with the occurrence of PRES-related seizures.
RESULTS: Of 100 patients, 70% experienced at least one seizure from PRES. On univariate analysis, the factors associated with seizures were the following: high Charlson comorbidity index (4.16±2.89 vs. 2.87±2.20, p=0.03), systemic malignancy (41.4% vs. 16.7%, p=0.02), occipital lobe involvement (97.1% vs. 83.3%, p=0.02), more lobes involved (4.6±1.48 vs. 3.9±1.32, p=0.03) but less likely in patients with visual disturbances (15.7% vs. 46.7%, p=0.005), and facial droop (12.9% vs. 16.7%, p=0.002). On multivariate analysis, only occipital lobe involvement was significantly (odds ratio: 9.63, 95% CI: 1.45-64.10, p=0.02) associated with the occurrence of PRES-related seizures. Despite the occurrence of seizures, they were less likely to require a nursing home placement upon hospital discharge (odds ratio: 0.17, 95% CI: 0.03-0.91, p=0.04).
CONCLUSION: We conclude that seizures are common in patients with occipital lobe involvement from PRES.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypertensive encephalopathy; Posterior reversible encephalopathy syndrome; Seizures

Mesh:

Year:  2016        PMID: 27337161     DOI: 10.1016/j.yebeh.2016.05.001

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

Review 1.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

2.  Different Clinicoradiological Characteristics of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post-Bone Marrow Transplantation Cases: A Retrospective Study.

Authors:  Hwazen Shash; Saad Aldaama; Hala Omer; Sameera Alafghani
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

Review 3.  Posterior Reversible Encephalopathy Syndrome.

Authors:  Alexandra N Gewirtz; Virginia Gao; Sarah C Parauda; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2021-02-25

4.  Posterior reversible encephalopathy syndrome while receiving irinotecan with fluorouracil and folinic acid for metastatic gastric cancer.

Authors:  Omar K Abughanimeh; Ayman H Qasrawi; Mohammad Y Tahboub; Mouhanna K Abu Ghanimeh
Journal:  BJR Case Rep       Date:  2017-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.